obesity drug news today glp-1 october 27 2025 GLP‑1 real‑world data for obesity: A new standard for metabolic care GLP-1 Drugs: Bridging Satiety, Nutrition,

Mounjaro is suitable for: Overweight or obese Have type 2 diabetes or insulin resistance Struggle with frequent hunger, cravings, or portion control Weight-related concerns such as high blood pressure or high cholesterol Committed to lifestyle changes, nutrition guidance, and follow-ups with doctors Mounjaro is NOT suitable for: Mounjaro is not for everyone because it affects your digestion, blood sugar response, and especially for those with medical conditions

[PMID:N/A]

Weintraub M

The magnitude of the benefits of GLP-1RA and SGLT-2 inhibitors on MACE are similar, ranging from 12 to 14% reduction of risk, but only GLP-1RA may reduce the risk of stroke

Diabetes Obes Metab (2019) 21:4348